These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 22680253
21. Use of effect size to determine optimal dose of duloxetine in major depressive disorder. Pritchett YL, Marciniak MD, Corey-Lisle PK, Berzon RA, Desaiah D, Detke MJ. J Psychiatr Res; 2007; 41(3-4):311-8. PubMed ID: 16934840 [Abstract] [Full Text] [Related]
25. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression. Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ. Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710 [Abstract] [Full Text] [Related]
27. Duloxetine in the treatment of elderly people with major depressive disorder. Del Casale A, Girardi P, Brugnoli R, Sani G, Di Pietro S, Brugnoli C, Caccia F, Angeletti G, Serata D, Rapinesi C, Tatarelli R, Kotzalidis GD. Riv Psichiatr; 2012 Aug; 47(6):479-88. PubMed ID: 23160108 [Abstract] [Full Text] [Related]
28. Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial. Englisch S, Knopf U, Scharnholz B, Kuwilsky A, Deuschle M, Zink M. J Psychopharmacol; 2009 Nov; 23(8):875-82. PubMed ID: 18583440 [Abstract] [Full Text] [Related]
29. Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment. Wang Y, Jia Y, Chen X, Ling X, Liu S, Xu G, Huang L. J Psychopharmacol; 2012 Nov; 26(11):1463-70. PubMed ID: 22706518 [Abstract] [Full Text] [Related]
30. Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder. Walderhaug E, Kasserman S, Aikins D, Vojvoda D, Nishimura C, Neumeister A. Pharmacopsychiatry; 2010 Mar; 43(2):45-9. PubMed ID: 20108200 [Abstract] [Full Text] [Related]
31. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine. Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J. Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007 [Abstract] [Full Text] [Related]
32. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil. Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA. Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599 [Abstract] [Full Text] [Related]
37. Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms. McIntyre RS, Konarski JZ. Expert Opin Pharmacother; 2005 May; 6(5):707-13. PubMed ID: 15934897 [Abstract] [Full Text] [Related]
38. Continuation treatment of major depressive disorder: is there a case for duloxetine? Norman TR, Olver JS. Drug Des Devel Ther; 2010 Feb 18; 4():19-31. PubMed ID: 20368904 [Abstract] [Full Text] [Related]